MoneyWorks4Me

Solara Active shines on getting EIR from USFDA for Mangalore facility

09 Nov 2018 Evaluate

Solara Active Pharma Science is currently trading at Rs. 314.90, up by 13.70 points or 4.55% from its previous closing of Rs. 301.20 on the BSE.

The scrip opened at Rs. 295.00 and has touched a high and low of Rs. 316.25 and Rs. 295.00 respectively. So far 7109 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 403.85 on 29-Aug-2018 and a 52 week low of Rs. 133.50 on 13-Jul-2018.

Last one week high and low of the scrip stood at Rs. 325.25 and Rs. 295.00 respectively. The current market cap of the company is Rs. 742.70 crore.

The promoters holding in the company stood at 37.90%, while Institutions and Non-Institutions held 24.30% and 37.80% respectively.

Solara Active Pharma Sciences has completed USFDA inspection at its multi-product API facility in Mangalore. As part of GMP compliance audit, the company has received Establishment Inspection Report (EIR) from USFDA, thereby confirming the closure of the inspection in July 2018.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Peers
Company Name CMP
Sun Pharma. Inds. 1848.00
Dr. Reddys Labs. 1198.65
Cipla 1408.75
Lupin 2084.00
Zydus Lifesciences 1190.50
View more..